首页> 外文期刊>Journal of viral hepatitis. >The relationship between HBV-DNA levels and cirrhosis-related complications in Chinese with chronic hepatitis B.
【24h】

The relationship between HBV-DNA levels and cirrhosis-related complications in Chinese with chronic hepatitis B.

机译:慢性乙型肝炎患者HBV-DNA水平与肝硬化相关并发症的关系

获取原文
获取原文并翻译 | 示例
       

摘要

We studied the hepatitis B virus (HBV)-DNA levels below which the development of cirrhosis-related complications became unlikely in chronic hepatitis B (CHB). Seventy-nine Chinese CHB patients with cirrhosis-related complications and 158 age-, sex- and HBeAg status-matched patients without complications were enrolled. The precore and core promoter mutations were detected by the Line Probe assay (LiPA). HBVDNA levels were determined by Digene assay and Cobas Amplicor Monitor test. Patients with complications had higher HBVDNA levels than those without complications (P = 0.02). HBeAg-positive patients with complications had similar alanine transferase (ALT) and HBVDNA levels and frequency of precore mutations, but higher frequency of core promoter mutations (P = 0.003), compared with those without complications. Anti-HBe-positive patients with complications had higher ALT and HBVDNA levels (P < 0.01) but similar frequency of precore and core promoter mutations, compared with those without complications. Anti-HBe patients (24.5%) with complications had HBVDNA levels <10(4) copies/mL. The major factor for the development of cirrhotic complications was viral loads but cirrhotic complications continued to develop in patients with HBVDNA levels below 10(4) copies/mL.
机译:我们研究了乙型肝炎病毒(HBV)-DNA的水平,低于该水平,在慢性乙型肝炎(CHB)中不太可能发生与肝硬化相关的并发症。纳入了79例中国CHB肝硬化相关并发症患者和158例年龄,性别和HBeAg状态匹配且无并发症的患者。通过线探针测定法(LiPA)检测前核心和核心启动子突变。 HBVDNA水平通过Digene测定和Cobas Amplicor Monitor测试确定。有并发症的患者的HBVDNA水平高于无并发症的患者(P = 0.02)。与无并发症者相比,有并发症的HBeAg阳性患者的丙氨酸转移酶(ALT)和HBVDNA水平及前核心突变频率相似,但核心启动子突变频率更高(P = 0.003)。与无并发症者相比,有并发症的抗HBe阳性患者的ALT和HBVDNA水平更高(P <0.01),但前核心和核心启动子突变的频率相似。具有并发症的抗HBe患者(24.5%)的HBVDNA水平<10(4)拷贝/ mL。肝硬化并发症发生的主要因素是病毒载量,但HBVDNA水平低于10(4)拷贝/ mL的患者肝硬化并发症继续发展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号